Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients

Digestive Diseases and Sciences

Volumn 57, Issue 4, 2012, Pages 897-904

  Song, Jianning ^a   Bai, Zhigang ^a   Han, Wei ^a   Zhang, Jun ^a   Meng, Hua ^a   Bi, Jintao ^a   Ma, Xuemei ^a   Han, Shiwei ^a   Zhang, Zhongtao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Circulating microRNA; Normalization; QPCR; Reference genes; Stomach neoplasms

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 16; MICRORNA 192; MICRORNA 21; MICRORNA 451; MICRORNA 93; MICRORNA LET 7A; UNCLASSIFIED DRUG;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; RNA EXTRACTION; RNA STABILITY; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL NUCLEOLAR; STOMACH NEOPLASMS;

EID: 84864055685     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1981-7     Document Type: Article

References (37)

1. Esquela-Kerscher A, Slack FJ. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-269.
2. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation. 2010;121:1022-1032.
3. Kolfschoten IG, Roggli E, Nesca V, Regazzi R. Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes Metab. 2009;11:118-129.
4. Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58:1375-1381.
5. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11: 136-146.
6. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006.
7. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-10518.
8. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101:2087-2092.
9. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672-675.
10. Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010; 102:1174-1179.
11. Liu R, Zhang C, Hu Z, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784-791.
12. Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microRNA- 21 concentrations in early and advanced breast cancer. Clin Chem. 2011;57:84-91.
13. Kanemaru H, Fukushima S, Yamashita J, et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci. 2011;61:187-193.
14. Kreth S, Heyn J, Grau S, et al. Identification of valid endogenous control genes for determining gene expression in human glioma. Neuro Oncol. 2010;12:570-579.
15. Davoren PA, McNeill RE, Lowery AJ, et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008;9:76.
16. Zhu HT, Dong QZ, Wang G et al. (2011) Identification of Suitable Reference Genes for qPCR Analysis of Circulating microRNAs in Hepatitis B Virus-Infected Patients. Mol Biotechnol. (Epub ahead of print). doi:10.1007/s12033-011-9414-6.
17. McNeill RE, Miller N, Kerin MJ. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol. 2007;8:107.
18. Profiling of microRNA in blood serum/plasma. Guidelines for the miRCURY LNATM Universal RT microRNA PCR System. Available at: http://www.exiqon.com/. Accessed 11 July 2011.
19. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245-5250.
20. Vandesompele J, De Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3: RESEARCH0034.
21. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26:509-515.
22. Thein SL, Silver N, Best S, Jiang J. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol. 2006; 7.
23. Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33: e179.
24. Tang F, Hajkova P, Barton SC et al. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res. 2006; 34: e9.
25. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008;14:844-852.
26. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qPCR). Methods. 2010;50: 298-301.
27. Chan SH, Wu CW, Li AF, et al. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res. 2008;28:907-911.
28. Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor growth. Oncogene. 2007;26:2799-2803.
29. Zhang Z, Li Z, Gao C, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 2008;88: 1358-1366.
30. Motoyama K, Inoue H, Mimori K, et al. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol. 2010;36:1089-1095.
31. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 MicroRNA family. Cell. 2005;120:635-647.
32. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102:13944-13949.
33. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13:272-286.
34. Piccolo S, Martello G, Rosato A, et al. A MicroRNA targeting dicer for metastasis control. Cell. 2010;141:U1195-U1276.
35. Ju JF, Song B, Wang Y, et al. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA Circuit. Clin Cancer Res. 2008;14:8080-8086.
36. Bandres E, Bitarte N, Arias F, et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res. 2009;15: 2281-2290.
37. Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J. 2001;20:3617-3622.